Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Generation of human induced pluripotential stem cells from individuals with complex heterozygous, isogenic corrected, and homozygous Bloc1s1 mutations

Stem Cell Research(2022)10.1016/j.scr.2022.102905Source: DataRank Database

Generation of human induced pluripotential stem cells from individuals with complex heterozygous, isogenic corrected, and homozygous Bloc1s1 mutations is a research paper published in Stem Cell Research (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 0.24)OA: goldTopics (32)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Asako Takanohashi ORCID,Sarah Woidill,Allen Seylani,Guy Helman ORCID,Patrícia Dias ORCID

Live enrichment

PubMed:36070637 OpenAlex:https://openalex.org/W4293660383

National Institute of Neurological Disorders and Stroke

Grant: SAP 4100077047

National Institute of Neurological Disorders and Stroke

Grant: U01NS106845

National Institute of Neurological Disorders and Stroke

Grant: U54 U54TR002823

NHLBI DIR

Grant: ZIA-HL005102

Intramural NIH HHS

Grant: ZIA HL005102

Biogen

Eli Lilly and Company

National Heart, Lung, and Blood Institute

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Center for Advancing Translational Sciences

National Institutes of Health

Takeda Pharmaceuticals North America

FWCI

0.24

Citation Percentile

0.5%

Citation Trend

2022

2024

goldLicense: cc-by-nc-nd

journalhttps://www.sciencedirect.com/science/article/pii/S1873506122002549/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S1873506122002549/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1873506122002549?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1873506122002549?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.scr.2022.102905

Fields of Study

CRISPR and Genetic EngineeringRNA Interference and Gene DeliveryRNA regulation and diseaseHumansHomozygoteInduced Pluripotent Stem CellsHeterozygoteMutationClustered Regularly Interspaced Short Palindromic RepeatsNerve Tissue Proteins

MeSH Terms

HeterozygoteHomozygoteHumansMutationNerve Tissue ProteinsInduced Pluripotent Stem CellsClustered Regularly Interspaced Short Palindromic Repeats

Keywords

BiologyCompound heterozygosityLeukodystrophyGeneticsHeterozygote advantagePoint mutationMutationGermlineMolecular biologyPhenotypeCell cultureMetachromatic leukodystrophyAlleleGeneBiochemistry